E. A. Fisher

Suppression of deferoxamine mesylate treatment — induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation

T. Kruck, D. C. McLachlan, E. A. Fisher, 1990, Clinical pharmacology and therapeutics.

Serum alkaline phosphatase in diabetes mellitus.

H. Estep, H. Ross-Clunis, E. A. Fisher, 1986, Journal of the American College of Nutrition.

A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate

T. Kruck, D. C. McLachlan, E. A. Fisher, 1993, Clinical pharmacology and therapeutics.

Atypical segregation of human red cell acid phosphatase phenotypes: evidence for a rare ‘silent’ allele Po

J. Herbich, D. Hopkinson, E. A. Fisher, 1970, Annals of human genetics.